BALTIMORE DAVID has a total of 19 patent applications. Its first patent ever was published in 1989. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are EDIGENE INC, NEW PORTAL LTD and INNOVIR LAB INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 13 | |
#2 | WIPO (World Intellectual Property Organization) | 5 | |
#3 | Canada | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement | |
#4 | Environmental technology | |
#5 | Agriculture | |
#6 | Machines |
# | Name | Total Patents |
---|---|---|
#1 | Baltimore David | 19 |
#2 | Taganov Konstantin | 4 |
#3 | Boldin Mark | 4 |
#4 | Yang Lili | 3 |
#5 | Corcoran Lynn M | 2 |
#6 | Lois-Caballe Carlos | 2 |
#7 | Pease Shirley | 2 |
#8 | Lu Wange | 2 |
#9 | Singh Harinder | 2 |
#10 | Baldwin Albert S Jr | 2 |
Publication | Filing date | Title |
---|---|---|
US2012064122A1 | Treatment of autoimmune inflammation using mir-155 | |
US2012065245A1 | Regulation of hematopoietic stem cell functions through microRNAs | |
US8313643B1 | System and method for analyzing a biological sample | |
WO2009079592A2 | Modulating immune system development and function through microrna mir-146 | |
US2008300211A1 | Microrna inhibition for the treatment of inflammation and myeloproliferative disorders | |
WO2005040347A2 | Methods and compositions for inhibiting cell growth and proliferation | |
WO03050262A2 | Method for the generation of antigen-specific lymphocytes |